We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Expressly for sale?

12 March 2007 By Robert Cyran

Express Scripts won t raise its $26bn hostile bid. That should guarantee CVS s merger gets approved at Friday s shareholder vote. But Express has a consolation gift it forced its rival to pony up another $3.2bn. Moreover, it may also have put itself in play.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)